Acute, next‐generation AMPK activation initiates a disease‐resistant gene expression program in dystrophic skeletal muscle

Overview of attention for article published in FASEB Journal, April 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Altmetric has seen 39 X posts from 34 X users, with an upper bound of 163,453 followers.

RT @WileyBiomedical: A new study by @NgsySean & team showcases a promising molecule for alleviating the symptoms of #Duchenne muscular dyst…

RT @WileyBiomedical: A new study by @NgsySean & team showcases a promising molecule for alleviating the symptoms of #Duchenne muscular dyst…

A new study by @NgsySean & team showcases a promising molecule for alleviating the symptoms of #Duchenne muscular dystrophy. Learn more in The FASEB Journal: https://t.co/wBiFo5xp2m #OpenAccess #AMPK @MacMODR @McMasterScience @FASEBorg https://t.co/S

RT @ToshifumiYokota: New research by Ng et al demonstrates that acute next-generation AMPK activation can initiate a disease-resistant gene…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 35 additional X posts.